{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:01:22Z","timestamp":1787313682530,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011103","name":"Sixth Framework Programme","doi-asserted-by":"publisher","award":["LSHM-CT-2005-018734"],"award-info":[{"award-number":["LSHM-CT-2005-018734"]}],"id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7-305707"],"award-info":[{"award-number":["FP7-305707"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00592-020-01612-7","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T15:02:40Z","timestamp":1603292560000},"page":"319-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-7287","authenticated-orcid":false,"given":"J.","family":"Weyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Verrijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hornemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vonghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dirinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"von Eckardstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vanwolleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Michielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Peiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Francque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"issue":"1","key":"1612_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000282081","volume":"28","author":"S Caldwell","year":"2010","unstructured":"Caldwell S, Argo C (2010) The natural history of non-alcoholic fatty liver disease. Dig Dis 28(1):162\u2013168","journal-title":"Dig Dis"},{"issue":"9","key":"1612_CR2","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/ijms17091575","volume":"17","author":"A Caligiuri","year":"2016","unstructured":"Caligiuri A, Gentilini A, Marra F (2016) Molecular pathogenesis of NASH. Int J Mol Sci 17(9):1969\u20131987","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1612_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P et al (2015) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149(2):389\u201397.e10","journal-title":"Gastroenterology"},{"issue":"5","key":"1612_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M et al (2015) Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61(5):1547\u20131554","journal-title":"Hepatology"},{"issue":"3","key":"1612_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19(3):175\u2013191","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1612_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/hmg\/ddv611","volume":"25","author":"H Bode","year":"2016","unstructured":"Bode H et al (2016) HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship. Hum Mol Genet 25(5):853\u2013865","journal-title":"Hum Mol Genet"},{"key":"1612_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.acr.2018.05.002","volume":"140","author":"M Nikolova-Karakashian","year":"2018","unstructured":"Nikolova-Karakashian M (2018) Sphingolipids at the crossroads of NAFLD and senescence. Adv Cancer Res 140:155\u2013190","journal-title":"Adv Cancer Res"},{"issue":"11","key":"1612_CR8","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger O et al (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 51(11):3299\u20133305","journal-title":"J Lipid Res"},{"key":"1612_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1476-511X-9-84","volume":"9","author":"M Bertea","year":"2010","unstructured":"Bertea M et al (2010) Deoxysphingoid bases as plasma markers in diabetes mellitus. Lipids Health Dis 9:84","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1612_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2337\/db13-1042","volume":"63","author":"RA Zuellig","year":"2014","unstructured":"Zuellig RA et al (2014) Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells. Diabetes 63(4):1326\u20131339","journal-title":"Diabetes"},{"issue":"43","key":"1612_CR11","doi-asserted-by":"publisher","first-page":"9488","DOI":"10.3748\/wjg.v22.i43.9488","volume":"22","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I et al (2016) Nonalcoholic fatty liver disease\u2014a multisystem disease? World J Gastroenterol 22(43):9488\u20139505","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1612_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.26510","volume":"59","author":"A Verrijken","year":"2014","unstructured":"Verrijken A et al (2014) Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 59(1):121\u2013129","journal-title":"Hepatology"},{"issue":"6","key":"1612_CR13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313\u20131321","journal-title":"Hepatology"},{"issue":"2","key":"1612_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/hep.27173","volume":"60","author":"P Bedossa","year":"2014","unstructured":"Bedossa P (2014) Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology 60(2):565\u2013575","journal-title":"Hepatology"},{"issue":"15","key":"1612_CR15","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","volume":"285","author":"A Penno","year":"2010","unstructured":"Penno A et al (2010) Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 285(15):11178\u201311187","journal-title":"J Biol Chem"},{"issue":"2","key":"1612_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00125-011-2384-1","volume":"55","author":"A Othman","year":"2012","unstructured":"Othman A et al (2012) Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome? Diabetologia 55(2):421\u2013431","journal-title":"Diabetologia"},{"issue":"3","key":"1612_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1194\/jlr.P056002","volume":"56","author":"DL Gorden","year":"2015","unstructured":"Gorden DL et al (2015) Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J Lipid Res 56(3):722\u2013736","journal-title":"J Lipid Res"},{"issue":"4","key":"1612_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/liv.14340","volume":"40","author":"Z Gai","year":"2020","unstructured":"Gai Z et al (2020) Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver disease. Liver Int 40(4):844\u2013859","journal-title":"Liver Int"},{"issue":"1","key":"1612_CR19","doi-asserted-by":"publisher","first-page":"e000073","DOI":"10.1136\/bmjdrc-2014-000073","volume":"3","author":"A Othman","year":"2015","unstructured":"Othman A et al (2015) Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus. BMJ Open Diabetes Res Care 3(1):e000073","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-020-01612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:46:45Z","timestamp":1634773605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-020-01612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s00592-020-01612-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Experimental protocols were approved by the Ethics Committee of the Antwerp University Hospital (reference 6\/25\/125, Belgian registration number B30020071389).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}